Italy· 046342022
STEGLUJAN*28 cpr rivestite 5 mg + 100 mg
A sitagliptin and ertugliflozin product containing sitagliptin/ertugliflozin, registered in Italy by MERCK SHARP & DOHME BV, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.
Checked against the register on
Informational only — not a medical device.
Where it is registered
Sitagliptin and ertugliflozin is registered in 10 of 19 countries.
Countries holding a registration under ATC A10BD24 (sitagliptin and ertugliflozin), each read from that country’s own register.
- This record: Italy
- 7 of them publish a price we can compare per daily dose
Sitagliptin and ertugliflozin · ATC A10BD24
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
- Active substance
- Sitagliptin/ertugliflozin
- Manufacturer
- MERCK SHARP & DOHME BV
- Country
- Italy (IT)
- ATC code
- A10BD24
- ATC class
- Sitagliptin and ertugliflozin
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic046342022STEGLUJAN*28 cpr rivestite 5 mg + 100 mgEUR 109
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A10BD24
Sitagliptin and ertugliflozin, as other registers publish it.
- IcelandSteglujanMerck Sharp & Dohme B.V.*
- FinlandSteglujanMerck Sharp & Dohme B.V.
- PolandSteglujanMerck Sharp & Dohme B.V.
- PolandSteglujanMerck Sharp & Dohme B.V.
- FinlandSteglujanMerck Sharp & Dohme B.V.
- DenmarkSteglujanMerck Sharp & Dohme B.V.
- IcelandSteglujanMerck Sharp & Dohme B.V.*
- DenmarkSteglujanMerck Sharp & Dohme B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/493fb53c-8024-4ea4-982b-aec9154b2c2e GET /v1/drugs/493fb53c-8024-4ea4-982b-aec9154b2c2e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 109,
"source": "aifa",
"currency": "EUR",
"strength": "ERTUGLIFLOZIN+SITAGLIPTIN 5MG+100MG 28 UNITA' USO ORALE",
"substance": "Sitagliptin/ertugliflozin",
"equivalence_group": "LZP",
"transparency_flag": null
}See everything about sitagliptin and ertugliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.